Search Results

Rockville, MD—The Association of Community Cancer Centers (ACCC) announced today the relaunch of the ACCC Immuno-Oncology Institute including an online resource portal for oncology professionals to find practical, proactive strategies for the effective delivery of new and emerging therapies. ACCC worked closely with a team of multispecialty thought leaders via the IO Institute Working Groups to develop …

Rockville, MD – As innovations in immunotherapies multiply, cancer programs and practices must overcome care coordination and communication challenges across the nation’s siloed healthcare system to integrate these advances into effective patient care. A new report from the Association of Community Cancer Centers (ACCC), Immuno-Oncology: Transforming the Delivery of Cancer Care in the Community, explores …

Recent advances in immunotherapy have launched an exciting new era for cancer treatment. However, to expand patient access to these groundbreaking therapies the oncology community must overcome evolving implementation and policy challenges. In support of efforts to identify and address these emerging issues, Association of Community Cancer Centers (ACCC) joined with other invited participants in …

ROCKVILLE, MD. – The Association of Community Cancer Centers (ACCC) announced that Merck, known as MSD outside the U.S. and Canada, is supporting ACCC’s Institute for Clinical Immuno-Oncology (ICLIO), with an educational grant. ICLIO is the first organization to prepare multidisciplinary cancer care providers for the complex implementation of immuno-oncology in the community setting. Merck’s support …

ROCKVILLE, Md. – The Association of Community Cancer Centers (ACCC) has launched the Institute for Clinical Immuno-Oncology (ICLIO), the first of its kind initiative aimed to rapidly facilitate the adoption of immuno-oncology in the community cancer setting. Immuno-oncology (I-O), a transformational paradigm in cancer treatment, puts the body’s own immune system to work to fight cancer. To help with …

ROCKVILLE, Md. – The Association of Community Cancer Centers (ACCC) has been provided with a charitable contribution from Bristol‐Myers Squibb to develop a comprehensive program in Immuno-Oncology for community-based providers. The contribution provided by Bristol-Myers Squibb will enable ACCC to establish the Institute for Clinical Immuno-Oncology (ICLIO) to educate providers about Immuno-Oncology …